Arbutus Biopharma Corp Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2022-10-24: Form 8-K; Exhibit 10.1; Description Third Amendment to Executive Employment Agreement, dated November 1, 2022, by and between the Company and Michael McElhaugh..
- 2022-05-31: Form 8-K; Exhibit 10.1; Description Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended.
- 2022-03-03: Form 10-K; Exhibit 10.41; Description Technology Transfer and Exclusive License Agreement, dated December 13, 2021, by and between the Company and Qilu Pharmaceutical Co., Ltd..
- 2022-03-03: Form 10-K; Exhibit 10.4; Description Form of Arbutus Biopharma Corporation Indemnity Agreement..
| Filed | Form | Exhibit | Description |
|---|
| 2022-10-24 | 8-K | 10.1 | Third Amendment to Executive Employment Agreement, dated November 1, 2022, by and between the Company and Michael McElhaugh. |
|---|
| 2022-05-31 | 8-K | 10.1 | Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended |
|---|
| 2022-03-03 | 10-K | 10.41 | Technology Transfer and Exclusive License Agreement, dated December 13, 2021, by and between the Company and Qilu Pharmaceutical Co., Ltd. |
|---|
| 2022-03-03 | 10-K | 10.4 | Form of Arbutus Biopharma Corporation Indemnity Agreement. |
|---|